+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
ID07258524

Using Total-Body PET Scans to Detect Disease Activity and Heart Disease Risk in Adults with ANCA-associated Vasculitis

Led by University of Edinburgh · Updated on 2026-02-12

120

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Antineutrophil cytoplasm antibody ANCA-associated vasculitis AAV is a serious autoimmune disease that causes inflammation in small blood vessels, leading to problems in multiple organs and potentially death if untreated. The condition is hard to diagnose and monitor because current methods are either inaccurate, invasive, or non-specific. Patients with AAV also face a high long-term risk of cardiovascular disease CVD. This research aims to evaluate total-body PET imaging using three radiotracers FDG, DOTATATE, and FAPI to better detect AAV activity and assess cardiovascular risk. Participants include people with active AAV and a matched control group without the disease. All will undergo baseline total-body PET scans with one or more radiotracers. They will also have cardiovascular risk assessments including 24-hour blood pressure monitoring, arterial stiffness tests, and retinal scans, plus blood and urine samples. Control participants complete the study after this visit. Those with AAV will return for repeat assessments once their disease is in remission, typically after 3 to 6 months. During the study, researchers will compare PET scan results and cardiovascular measures between groups and over time. They will measure changes in radiotracer uptake and correlate these with disease activity markers and cardiovascular risk factors. All study activities will take place at the University of Edinburgh research facilities. This observational study seeks to improve understanding and management of AAV and its cardiovascular complications through advanced imaging techniques.

CONDITIONS

Brief Title

PET Assessment of Disease Activity and Cardiovascular Disease Risk in ANCA-associated Vasculitis

Research Team

N

Neeraj Dhaun, MBChB PhD

D

Dan Pugh, MBChB PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here